Atlas Trials

Adrenocorticotropic Hormone (ACTH) for Post-op Inflammation in Proliferative Vitreoretinopathy (PVR)

Clinical trial NCT03727776 · COMPLETED

Trial details

NCT number
NCT03727776
Sponsor
Johns Hopkins University
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Proliferative Vitreoretinopathy
Start date
2019-08-19
Primary completion
2023-07-07
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.